机译:儿童急性髓性白血病中FLT3和核磷蛋白基因突变的发生率:塞尔维亚的经验和文献综述
Department of Hematology/Oncology, University Children Hospital, Medical Faculty University of Belgrade, Belgrade, Serbia;
Laboratory for Molecular Hematology, Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia;
Department of Hematology/Oncology, University Children Hospital, Medical Faculty University of Belgrade, Belgrade, Serbia;
Department of Hematology/Oncology, University Children Hospital, Medical Faculty University of Belgrade, Belgrade, Serbia;
Department of Hematology, Mother and Child Healthcare Institute “Dr Vukan Cupic”, Belgrade, Serbia;
Laboratory for Molecular Hematology, Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia;
Laboratory for Molecular Hematology, Institute of Molecular Genetics and Genetic Engineering, Belgrade, Serbia;
FLT3 mutations; NMP1 mutations; Acute myeloid leukemia; Children;
机译:儿童急性髓性白血病中FLT3和核磷蛋白基因突变的发生率:塞尔维亚的经验和文献综述。
机译:FLT3内部串联复制,核磷蛋白1和CEBPA基因突变对核型正常且年龄小于60岁的急性髓样白血病患者的预后意义:系统评价和荟萃分析
机译:东南亚急性髓性白血病中的核蛋白突变:八个新变异,NMP1 / FLT3突变的FLT3共存和预后影响血液学
机译:RAS基因突变在急性髓性白血病和髓细胞增强综合征中:荟萃分析其发生和预后相关性
机译:ALK和FLT3激酶抑制剂对非小细胞肺癌细胞和急性髓系白血病细胞的癌症驱动突变的药理作用
机译:细胞遗传学正常的急性髓细胞性白血病成年患者中核磷酸蛋白突变和FLT3内部串联重复的预后意义
机译:成年细胞遗传学上正常的急性髓性白血病患者中核磷酸蛋白突变和FLT3内部串联重复的预后意义